Business
Notice of Capital Markets Day
IXICO plc will host a Capital Markets Day for analysts and institutional investors on October 30, 2025, from 14:00 to 17:00 GMT at Cavendish Capital Markets' offices. The event will cover IXICO's growth strategy, future direction, neuroscience landscape trends, expansion opportunities, technology roadmap, and AI-driven precision medicine technology platform. Existing and prospective retail investors can join via a live webcast with the ability to submit questions. Registration for the webcast is available through Investor Meet Company. Disclaimer*
About this update from Ixico Plc
[{"type":"text","content":"\n\nIXICO plc\n(\"IXICO\", the \"Company\" or the \"Group\")\n \nNotice of Capital Markets Day\n \n \n30 September 2025 IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announces it will be hosting a Capital Markets Day for analysts and institutional investors between 14:00 - 17:00 GMT on 30 October 2025 at the offices of Cavendish Capital Markets.\n \nThe event will provide the opportunity to hear from IXICO's CEO and strengthened senior management team, key customers and industry opinion leaders. The agenda will explore the Company's growth strategy and future direction, the neuroscience landscape trends and expansion opportunities for the Company, IXICO's technology roadmap and a detailed explanation of IXICO's AI-driven precision medicine technology platform\n \nExisting and prospective retail investors are welcome to join via a live webcast. The facility to submit questions will be available on this platform.\n \nTo register your interest please contact Cavendish Capital Markets on +44 (0) 20 7220 0500 or via email [email protected]\n \nTo register for the live webcast investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via: https://www.investormeetcompany.com/ixico-plc/register-investor\n \n \nEnds\n \nFor further information please contact:\n\n\n\n\nIXICO plc\n\n\n+44 (0) 20 3763 7499\n\n\n\n\nGrant Nash, Chief Financial Officer\nJames Chandler, Chief Business Officer\n\n\n\n\n\n\n\n \nCavendish Capital Markets Limited\n(Nominated Adviser and Sole Broker)\n\n\n \n+44 (0) 20 7220 0500\n\n\n\n\nGiles Balleny / Isaac Hooper (Corporate Finance)\nNigel Birks (Healthcare Specialist Sales)\nHarriet Ward (Corporate Broking)\nMichael F Johnson (Sales)\n\n\n\n\n\n\n\n \n \nAbout IXICO www.IXICO.com\nIXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. As a key part of the global neurological disease research community, the Company has built a global reputation and ...